Orgenesis Inc (ORGS)
0.58
+0.03
(+4.69%)
USD |
NASDAQ |
May 10, 16:00
0.5701
-0.01
(-1.71%)
After-Hours: 20:00
Orgenesis Shareholders Equity (Quarterly): -20.98M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -20.98M |
September 30, 2023 | 12.40M |
June 30, 2023 | 23.96M |
March 31, 2023 | 27.67M |
December 31, 2022 | 27.56M |
September 30, 2022 | 30.21M |
June 30, 2022 | 31.75M |
March 31, 2022 | 34.70M |
December 31, 2021 | 38.49M |
September 30, 2021 | 43.12M |
June 30, 2021 | 51.36M |
March 31, 2021 | 54.55M |
December 31, 2020 | 52.58M |
September 30, 2020 | 86.66M |
June 30, 2020 | 88.23M |
March 31, 2020 | 89.51M |
December 31, 2019 | 5.477M |
September 30, 2019 | 10.47M |
June 30, 2019 | 16.12M |
March 31, 2019 | 20.76M |
November 30, 2018 | 28.35M |
August 31, 2018 | 29.62M |
May 31, 2018 | 25.80M |
February 28, 2018 | 19.48M |
November 30, 2017 | 14.12M |
Date | Value |
---|---|
August 31, 2017 | 11.25M |
May 31, 2017 | 9.898M |
February 28, 2017 | 5.715M |
November 30, 2016 | 12.50M |
August 31, 2016 | 13.84M |
May 31, 2016 | 15.53M |
February 29, 2016 | 16.68M |
November 30, 2015 | -6.44M |
August 31, 2015 | -5.960M |
May 31, 2015 | -5.048M |
February 28, 2015 | -3.623M |
November 30, 2014 | -2.979M |
August 31, 2014 | -4.098M |
May 31, 2014 | -1.586M |
February 28, 2014 | -1.699M |
November 30, 2013 | -2.034M |
August 31, 2013 | -1.306M |
May 31, 2013 | -0.968M |
February 28, 2013 | -0.2599M |
November 30, 2012 | -0.2806M |
August 31, 2012 | 0.1565M |
May 31, 2012 | -0.0616M |
February 29, 2012 | 0.1941M |
November 30, 2011 | -0.0827M |
August 31, 2011 | -0.0208M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-20.98M
Minimum
Dec 2023
89.51M
Maximum
Mar 2020
37.04M
Average
31.75M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
Altimmune Inc | 194.10M |
Verastem Inc | 57.37M |
Oragenics Inc | 3.168M |
Actinium Pharmaceuticals Inc | 43.86M |
Dare Bioscience Inc | -5.048M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 14.55M |
Total Liabilities (Quarterly) | 35.54M |
Debt to Equity Ratio | -1.062 |
Current Ratio | 0.2484 |
Net Debt Paydown Yield | 6.72% |